Synexus recognised by GrowthAccelerator
Synexus, the Lyceum Capital-backed leading international clinical research site group, has been identified as a ‘Hyper Growth’ business by GrowthAccelerator, the Government’s business growth advisory service.
GrowthAccelerator identified a breed of rapidly-expanding SMEs — dubbed Hyper Growth firms — in a unique study led by a panel of leading business growth experts from across industry and academia. The findings are included in a report, the Hyper Growth Insights Study.
Since investment from Lyceum in 2007, Synexus has grown its forward order book to £100m and expended into Eastern Europe.
Christophe Berthoux, CEO of Synexus, said: “We are delighted to have been identified as a hyper growth company. We believe that providing excellent service quality and speed for our clients, as well as putting in place ongoing management training and development programmes across the business, have been a key driver in our success, which this report highlights.”
Stephen Peacock, Director of Operations at GrowthAccelerator, added: “This study seeks to shed light on the attitude and approach of a select group of leaders from exceptionally high-performing businesses.
“By looking at the nature, characteristics and approach of the leaders behind these businesses, we believe this report makes a valuable contribution to the high-growth debate, raising implications for policy and action to stimulate and support future business growth.”